ALLOGENE THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+5.3% +$3M
$-53M
Free Cash Flow↑+100.0% +$257K
$0
Investing Cash Flow↓-38.8% -$21M
$34M
Financing Cash Flow↑+36.8% +$2M
$8M
Capex↓-100.0% -$257K
$0
Stock-Based Comp↓-36.8% -$5M
$8M
D&A↓-5.4% -$176K
$3M
SBC Allocated Expense↓-36.7% -$5M
$8M